| Characteristic | EBITDA in million U.S. dollars |
|---|---|
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
The chart is not accessible to screen readers. Please switch to the table view to access the data.
Download
Source
Release date
March 2024
Region
Singapore
Survey time period
2014 to 2023
Supplementary notes
Earnings before tax, non-controlling interests, interest on borrowings, depreciation and amortization, changes in fair value of biological assets, foreign exchange gain or loss and exceptional items.
Figures are rounded.
Citation formats









